CAH treatment may be linked to lower bone mineral density

Higher glucocorticoid doses for adults with CAH may be associated with lower bone mineral density, especially among women and those prescribed prednisolone, according to findings published in Clinical Endocrinology.
Recent Blog Posts
Webinar: Quality of life and fertility in CAH – 21st November 2026
In this free webinar, join experts across Europe discussing quality of life and fertility in CAH.
Supporting Safer Adrenal Crisis Care
The Addison’s Disease Self-Help Group (ADSHG) has launched a national advocacy campaign to improve emergency treatment and patient safety for people at risk of adrenal crisis. The campaign was sparked by the discontinuation of liquid hydrocortisone in the UK, which...
Pituitary Awareness Month (October) – Symptoms in the Spotlight
Read more at this link…


